Asymmetric Dimethyl-l-Arginine is a Biomarker for Disease Stage and Follow-Up of Pulmonary Hypertension Associated with Congenital Heart Disease

Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary arterial hypertension associated with congenital heart disease

(2014) Antonio Lopes et al.   Annals of Thoracic Medicine

Biomarkers in Pulmonary Hypertension

(2013) Vasile Foris et al.   CHEST

Pulmonary Arterial Hypertension Associated with Congenital Heart Disease

(2013) Usha Krishnan et al.   CLINICS IN CHEST MEDICINE

Asymmetric dimethylarginine levels in children with sickle cell disease and its correlation to tricuspid regurgitant jet velocity

(2013) Mohamed El-Shanshory et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Elevated Homocysteine and Asymmetric Dimethyl Arginine Levels in Pulmonary Hypertension Associated With Congenital Heart Disease

(2012) Cihat Sanli et al.   PEDIATRIC CARDIOLOGY

Pulmonary Hypertension Associated with Congenital Heart Disease: A Practical Review for the Pediatric Cardiologist

(2012) W. Buck Kyle   Congenital Heart Disease

Serum Asymmetric Dimethylarginine, Nitrate, Vitamin B12, and Homocysteine Levels in Individuals with Pulmonary Embolism

(2011) Murat Altuntaş et al.   MEDIATORS OF INFLAMMATION

Hipertensión pulmonar en los cortocircuitos congénitos

(2011) Maurice Beghetti et al.   REVISTA ESPANOLA DE CARDIOLOGIA

Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)

(2009) et al.   EUROPEAN HEART JOURNAL

Biomarkers in pulmonary hypertension

(2008) G. Warwick et al.   EUROPEAN RESPIRATORY JOURNAL